Pfizer withdraws application for emergency use of its COVID-19 vaccine in India: Reports

New Delhi: Pfizer withdraws application for emergency use of its COVID-19 vaccine in India, reported Reuters.

“In pursuance of the Emergency Use Authorisation of its COVID-19 vaccine, Pfizer participated in the Subject Expert Committee meeting of the Drug Regulatory Authority of India on February 3. Based on the deliberations at the meeting and our understanding of additional information that the regulator may need, the company has decided to withdraw its application at this time,” a company spokesperson said in a statement.

“Pfizer remains committed to making its vaccine available for use by the Government in India and to pursuing the requisite pathway for emergency use authorisation that enables the availability of this vaccine for any future deployment,” the spokesperson said.

Pfizer in its application submitted to the drug regulator in December 2020, had sought permission to import the vaccine for sale and distribution in India, besides waiver of clinical trials on Indian population in accordance with the special provisions under the New Drugs and Clinical Trials Rules, 2019, official sources had told PTI.

covid, vaccine, vaccination, covid-19 (8)

 

The post Pfizer withdraws application for emergency use of its COVID-19 vaccine in India: Reports appeared first on NewsroomPost.



from NewsroomPost https://ift.tt/3jiCuMQ
https://ift.tt/2YPbRWB

Comments